Literature DB >> 32502310

Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.

Na Zhao1,2, Hien Dang1, Lichun Ma1, Sean P Martin1, Marshonna Forgues1, Kris Ylaya3, Stephen M Hewitt3, Xin Wei Wang1,4.   

Abstract

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is an aggressive malignancy which is often associated with a complex tumor microenvironment attributable to etiology-induced cellular inflammation. γδ T cells are known to detect and react to chronic inflammation, which is linked to cancer development, progression, and metastasis. Our recent genomic study revealed an increased infiltration of several immune cell types, including γδ T cells, in tumor microenvironments of a Thai HCC subtype associated with a good prognosis. APPROACH AND
RESULTS: Here, we quantified the amount of γδ T cells using a γδ T-cell-specific gene signature in 247 Chinese HCC patients. We also validated the γδ T-cell signature in American HCC patients. Additionally, such an association was only found in tumor transcriptomic data, but not in adjacent nontumor transcriptomic data, suggesting a selective enrichment of γδ T cells in the tumor microenvironment. Moreover, the γδ T-cell signature was positively correlated with the expression of natural killer cell receptor genes, such as NKG2D and cytolytic T-cell genes granzymes and perforin, suggesting a stronger T-cell-mediated cytotoxic activity. Furthermore, we found that the γδ T-cell-specific gene expression is positively correlated with the expression of chemokine (C-C motif) ligand 4 (CCL4)/chemokine (C-C motif) ligand 5 (CCL5) and C-C chemokine receptor type 1 (CCR1)/C-C chemokine receptor type 5 (CCR5), the receptors for γδ T cells. We validated these results using immunohistochemical analysis of formalin-fixed, paraffin-embedded tumor biopsies from 182 HCC patients. Moreover, we found evidence of CCL4/CCL5-mediated recruitment of γδ T cells both in vitro and in a murine orthotopic Hepa1-6 HCC model.
CONCLUSIONS: We propose that CCL4/CCL5 may interact with their receptor, CCR1/CCR5, which may facilitate the recruitment of γδ T cells from peripheral blood or peritumor regions to the tumor regions. Consequently, an increasing infiltration of γδ T cells in tumors may enhance antitumor immunity and improve patients' prognosis.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32502310      PMCID: PMC9175512          DOI: 10.1002/hep.31412

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.298


  33 in total

Review 1.  A history of exploring cancer in context.

Authors:  Shelly Maman; Isaac P Witz
Journal:  Nat Rev Cancer       Date:  2018-06       Impact factor: 60.716

2.  Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection.

Authors:  Xiao-Yan Cai; Jia-Xing Wang; Yong Yi; Hong-Wei He; Xiao-Chun Ni; Jian Zhou; Yun-Feng Cheng; Jian-Jun Jin; Jia Fan; Shuang-Jian Qiu
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 3.  CCL5 as an adjuvant for cancer immunotherapy.

Authors:  Natalia Lapteva; Xue F Huang
Journal:  Expert Opin Biol Ther       Date:  2010-05       Impact factor: 4.388

Review 4.  γδ T cells in homeostasis and host defence of epithelial barrier tissues.

Authors:  Morten M Nielsen; Deborah A Witherden; Wendy L Havran
Journal:  Nat Rev Immunol       Date:  2017-09-18       Impact factor: 53.106

5.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

Authors:  Stephanie Roessler; Hu-Liang Jia; Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Ju-Seog Lee; Snorri S Thorgeirsson; Zhongtang Sun; Zhao-You Tang; Lun-Xiu Qin; Xin Wei Wang
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

Authors:  Jittiporn Chaisaingmongkol; Anuradha Budhu; Hien Dang; Siritida Rabibhadana; Benjarath Pupacdi; So Mee Kwon; Marshonna Forgues; Yotsawat Pomyen; Vajarabhongsa Bhudhisawasdi; Nirush Lertprasertsuke; Anon Chotirosniramit; Chawalit Pairojkul; Chirayu U Auewarakul; Thaniya Sricharunrat; Kannika Phornphutkul; Suleeporn Sangrajrang; Maggie Cam; Ping He; Stephen M Hewitt; Kris Ylaya; Xiaolin Wu; Jesper B Andersen; Snorri S Thorgeirsson; Joshua J Waterfall; Yuelin J Zhu; Jennifer Walling; Holly S Stevenson; Daniel Edelman; Paul S Meltzer; Christopher A Loffredo; Natsuko Hama; Tatsuhiro Shibata; Robert H Wiltrout; Curtis C Harris; Chulabhorn Mahidol; Mathuros Ruchirawat; Xin W Wang
Journal:  Cancer Cell       Date:  2017-06-22       Impact factor: 31.743

7.  DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.

Authors:  Olivier Toutirais; Florian Cabillic; Gaëlle Le Friec; Samuel Salot; Pascal Loyer; Matthieu Le Gallo; Mireille Desille; Cécile Thomas de La Pintière; Pascale Daniel; Françoise Bouet; Véronique Catros
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

Review 8.  Role of gamma-delta T cells in liver inflammation and fibrosis.

Authors:  Linda Hammerich; Frank Tacke
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

9.  Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.

Authors:  Chel Hun Choi; Joon-Yong Chung; Jae-Hoon Kim; Byoung-Gie Kim; Stephen M Hewitt
Journal:  J Transl Med       Date:  2016-05-06       Impact factor: 5.531

Review 10.  Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease.

Authors:  Neil Rajoriya; Joannah Ruth Fergusson; Joanna A Leithead; Paul Klenerman
Journal:  Front Immunol       Date:  2014-08-26       Impact factor: 7.561

View more
  13 in total

Review 1.  Basophils as a potential therapeutic target in cancer.

Authors:  Jicheng Zhang; Hanlin Yin; Qiangda Chen; Guochao Zhao; Wenhui Lou; Wenchuan Wu; Ning Pu
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

Review 2.  Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.

Authors:  José Saura-Esteller; Milon de Jong; Lisa A King; Erik Ensing; Benjamin Winograd; Tanja D de Gruijl; Paul W H I Parren; Hans J van der Vliet
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.

Authors:  Jan Korbecki; Szymon Grochans; Izabela Gutowska; Katarzyna Barczak; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

Review 4.  Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis.

Authors:  Minjie Wan; Jiawen Han; Lili Ding; Feng Hu; Pujun Gao
Journal:  Front Med (Lausanne)       Date:  2021-04-01

Review 5.  Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection.

Authors:  Wen Hou; Xiaoli Wu
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

6.  Identification of Genes Potentially Associated with Melanoma Tumorigenesis Through Co-Expression Network Analysis.

Authors:  Xiuyun Xuan; Yuqi Wang; Yanhong Sun; Changzheng Huang
Journal:  Int J Gen Med       Date:  2021-11-19

7.  Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment.

Authors:  Zhongyi Jiang; Changchang Xing; Pusen Wang; Xueni Liu; Lin Zhong
Journal:  Front Cell Dev Biol       Date:  2021-12-06

8.  Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma.

Authors:  Qun Cai; Mingyan Zhu; Jinnan Duan; Hao Wang; Jingdan Chen; Yixin Xiao; Yangqin Wang; Jianfang Wang; Xuewen Yu; Hui Yang
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

9.  CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer.

Authors:  Yichun Tang; Yueyang Hu; Yuchun Niu; Lei Sun; Linlang Guo
Journal:  Front Med (Lausanne)       Date:  2022-02-17

Review 10.  The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

Authors:  Susann Schönefeldt; Tamara Wais; Marco Herling; Satu Mustjoki; Vasileios Bekiaris; Richard Moriggl; Heidi A Neubauer
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.